These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12830466)

  • 1. Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena?
    Badalamenti S; Catania A; Lunghi G; Covini G; Bredi E; Brancaccio D; Salvadori M; Como G; Ponticelli C; Graziani G
    Am J Kidney Dis; 2003 Jul; 42(1):143-50. PubMed ID: 12830466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Gerosa S; Vinson S; Mousa M; Gitnick G
    Nephron; 1998 Dec; 80(4):428-33. PubMed ID: 9832642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight.
    Fabrizi F; Messa P; Martin P
    Int J Artif Organs; 2009 Jan; 32(1):1-11. PubMed ID: 19241358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of hepatitis C virus load during hemodialysis: novel perspectives.
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(4):467-75. PubMed ID: 14696748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis.
    Mizuno M; Higuchi T; Yanai M; Kanmatsuse K; Esumi M
    Nephron; 2002 Jun; 91(2):235-42. PubMed ID: 12053059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of hepatitis C virus load and hemodialysis: is there any influence of the reuse of dialysis membrane on HCV viremia?
    Martins RS; Martins Filho OA; Gonçales NS; del Castillo DM; Silva LD; Faria LC; Teixeira R
    Scand J Infect Dis; 2012 Mar; 44(3):190-6. PubMed ID: 22066851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Vinson S; Mousa M; Gitnick G
    Am J Kidney Dis; 2000 Jan; 35(1):122-9. PubMed ID: 10620553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of Hepatitis B virus load during haemodialysis sessions and α-interferon: a prospective study.
    Fabrizi F; Lunghi G; Alongi G; Aucella F; Barbisoni F; Bisegna S; Mangano S; Romei-Longhena G; Artoni A; Bettoni G; Messa P; Martin P
    Kidney Blood Press Res; 2013; 37(4-5):286-94. PubMed ID: 24022371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit.
    Covic A; Maftei ID; Mardare NG; Ioniţă-Radu F; Totolici C; Tuţă L; Golea O; Covic M; Volovăţ C; Gusbeth-Tatomir P; Mircescu G
    J Nephrol; 2006; 19(6):794-801. PubMed ID: 17173254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
    González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
    Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.
    Selcuk H; Kanbay M; Korkmaz M; Gur G; Akcay A; Arslan H; Ozdemir N; Yilmaz U; Boyacioglu S
    Dig Dis Sci; 2006 Aug; 51(8):1420-5. PubMed ID: 16868830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of hepatitis C virus RNA in blood of infected patients under maintenance haemodialysis with high-biocompatibility, high-permeability filters.
    Angelico M; Morosetti M; Passalacqua S; Chiappini MG; Botta S; Ombres D; Splendiani G; Casciani CU
    Dig Liver Dis; 2000 Nov; 32(8):724-8. PubMed ID: 11142584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches in the therapy of hepatitis C in dialysis patients.
    Sikole A; Dzekova P; Asani A; Amitov V; Selim G; Gelev S; Polenakovic M
    Prilozi; 2008 Dec; 29(2):155-64. PubMed ID: 19259044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Gerosa S; Mousa M; Gitnick G
    Am J Kidney Dis; 1998 Apr; 31(4):647-54. PubMed ID: 9531181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
    Potthoff A; Wiegand J; Lüth JB; Wedemeyer H; Manns MP; Tillmann HL
    Clin Nephrol; 2005 Mar; 63(3):232-5. PubMed ID: 15786827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.